INTERNATIONAL PATENT: CRINETICS PHARMACEUTICALS, INC. FILES APPLICATION FOR "SOMATOSTATIN SUBTYPE RECEPTOR 3 (SSTR3) AGONISTS AND USES THEREOF"

GENEVA, June 4 -- CRINETICS PHARMACEUTICALS, INC. (6055 Lusk Blvd.San Diego, California 92121) filed a patent application (PCT/US2024/056625) for "SOMATOSTATIN SUBTYPE RECEPTOR 3 (SSTR3) AGONISTS AND USES THEREOF" on Nov 20, 2024. With publication no. WO/2025/111318, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KIM, Sun Hee (6055 Lusk Blvd.San Diego, California 92121), ZHU, Yunfei (6055 Lusk Blvd.San Diego, California 92121)

Abstract: Described herein are compounds that are somatostatin receptor subtype 3 (SSTR3) ag...